Cell Biology · Provider Reference

Muse Cells vs. MSCs

Muse cells aren't a competing category to MSCs — they're a distinct subpopulation found within mesenchymal cell sources. Here's how the two compare.

Where They Overlap

Muse cells are not isolated from a separate tissue source — they occur naturally as a subpopulation within standard mesenchymal cell sources, including bone marrow, adipose tissue, and umbilical cord-derived cell populations. In that sense, every MSC preparation may contain some fraction of Muse cells, unless specifically sorted or selected against.

Where They Diverge

FeatureConventional MSCMuse Cell
Defining markersCD73+, CD90+, CD105+; CD34/CD45/HLA-DR–SSEA-3+ in addition to mesenchymal markers
Differentiation rangeTrilineage: bone, cartilage, fat (mesodermal)Broader, pluripotent-like — reported across all three germ layers
Stress toleranceStandard — sensitive to harsh conditionsDefining trait — survives conditions lethal to most adult cells
Population statusBroad, heterogeneous population meeting ISCT minimal criteriaNarrower subpopulation identified within MSC sources

Why the Distinction Matters

Because Muse cells are a subset rather than a separately sourced cell type, a product labeled as containing Muse cells should specify how that subpopulation is identified or enriched — typically via SSEA-3 marker analysis — rather than relying on the assumption that any MSC-sourced product automatically contains a clinically meaningful Muse cell fraction.

References

  1. Dominici M, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006. View source →
  2. Kuroda Y, et al. Unique multipotent cells in adult human mesenchymal cell populations. Proc Natl Acad Sci USA. 2010. View source →

This page is educational reference material for licensed healthcare providers and does not constitute medical, legal, or regulatory advice. HCT/P products are not FDA-approved.